The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
Open accessAbstract
BACKGROUND: Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use for respiratory infections. However, the accuracy of procalcitonin to discriminate between viral and bacterial pneumonia requires further dissection. METHODS: We evaluated the association between serum procalcitonin concentration at hospital admission with pathogens detected in a multicenter prospective surveillance study of adults hospitalized with community-acquired pneumonia. Systematic pathogen testing included cultures, serology, urine antigen tests, and molecular detection. Accuracy of procalcitonin to discriminate between viral and bacterial pathogens was calculated. RESULTS: Among 1735 patients, pathogens were identified in 645 (37%), including 169 (10%) with typical bacteria, 67 (4%) with atypical bacteria, and 409 (24%) with viruses only. Median procalcitonin concentration was lower with viral pathogens (0.09 ng/mL; interquartile range [IQR], <0.05-0.54 ng/mL) than atypical bacteria (0.20 ng/mL; IQR, <0.05-0.87 ng/mL; P = .05), and typical bacteria (2.5 ng/mL; IQR, 0.29-12.2 ng/mL; P < .01). Procalcitonin discriminated bacterial pathogens, including typical and atypical bacteria, from viral pathogens with an area under the receiver operating characteristic (ROC) curve of 0.73 (95% confidence interval [CI], .69-.77). A procalcitonin threshold of 0.1 ng/mL resulted in 80.9% (95% CI, 75.3%-85.7%) sensitivity and 51.6% (95% CI, 46.6%-56.5%) specificity for identification of any bacterial pathogen. Procalcitonin discriminated between typical bacteria and the combined group of viruses and atypical bacteria with an area under the ROC curve of 0.79 (95% CI, .75-.82). CONCLUSIONS: No procalcitonin threshold perfectly discriminated between viral and bacterial pathogens, but higher procalcitonin strongly correlated with increased probability of bacterial pathogens, particularly typical bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Self-citationDellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
Self-citationCommunity-Acquired Pneumonia Requiring Hospitalization among U.S. Children
Jain, S., Williams, D. J., Arnold, S. R., Ampofo, K., Bramley, A. M., Reed, C., Stockmann, C., Anderson, E. J., Grijalva, C. G., Self, W. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405870 · Cited by 1,804
Self-citationRuuskanen, O., Lahti, E., Jennings, L. C., & Murdoch, D. R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61459-6 · Cited by 1,124
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00053-0 · Cited by 836
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
Caliendo, A. M., Gilbert, D. N., Ginocchio, C. C., Hanson, K. E., May, L., Quinn, T. C., Tenover, F. C., Alland, D., Blaschke, A. J., Bonomo, R. A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit578 · Cited by 628
Self-citationLinscheid, P., Seboek, D., Nylen, E. S., Langer, I., Schlatter, M., Becker, K. L., Keller, U., & Müller, B. (2003) · Endocrinology · doi:10.1210/en.2003-0854 · Cited by 359
Dare, R. K., Fry, A. M., Chittaganpitch, M., Sawanpanyalert, P., Olsen, S. J., & Erdman, D. D. (2007) · The Journal of Infectious Diseases · doi:10.1086/521308 · Cited by 333
Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis
Muller, B. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.396 · Cited by 324
Self, W. H., Williams, D. J., Zhu, Y., Ampofo, K., Pavia, A. T., Chappell, J. D., Hymas, W. C., Stockmann, C., Bramley, A. M., Schneider, E., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv323 · Cited by 273
Self-citationDiagnosis ofLegionellaInfection
Murdoch, D. R. (2003) · Clinical Infectious Diseases · doi:10.1086/345529 · Cited by 270
Murdoch, D. R., Laing, R. T. R., Mills, G. D., Karalus, N. C., Town, G. I., Mirrett, S., & Reller, L. B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3495-3498.2001 · Cited by 264
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub2 · Cited by 264
Charles, P. G. P., Whitby, M., Fuller, A. J., Stirling, R., Wright, A. A., Korman, T. M., Holmes, P. W., Christiansen, K. J., Waterer, G. W., Pierce, R. J. P., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586749 · Cited by 225
Self-citationDiagnostic Tests for Agents of Community-Acquired Pneumonia
Bartlett, J. G. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir045 · Cited by 222
Procalcitonin as a Biomarker in Respiratory Tract Infection
Gilbert, D. N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir050 · Cited by 151
the CAPNETZ study group, Krüger, S., Ewig, S., Papassotiriou, J., Kunde, J., Marre, R., von Baum, H., Suttor, N., & Welte, T. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-65 · Cited by 146
Branche, A. R., Walsh, E. E., Vargas, R. L., Hulbert, B., Formica, M. A., Baran, A. M., Peterson, D. R., & Falsey, A. R. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv252 · Cited by 126
Thurman, K. A., Warner, A. K., Cowart, K. C., Benitez, A. J., & Winchell, J. M. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.11.014 · Cited by 96
Weinberg, G. A., Schnabel, K. C., Erdman, D. D., Prill, M. M., Iwane, M. K., Shelley, L. M., Whitaker, B., Szilagyi, P. G., & Hall, C. B. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.03.016 · Cited by 92
Musher, D. M., Bebko, S. P., & Roig, I. L. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit579 · Cited by 29
Feikin, D. R., Njenga, M. K., Bigogo, G., Aura, B., Gikunju, S., Balish, A. L., Katz, M. A., Erdman, D. D., & Breiman, R. F. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00325-12 · Cited by 27
Sawatwong, P., Chittaganpitch, M., Hall, H. E., Peruski, L. F., Xu, X., Baggett, H. C., Fry, A. M., Erdman, D. D., & Olsen, S. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir710 · Cited by 17
Gilbert, D. N. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv253 · Cited by 8
(2008) · PubMed
Cited by
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Self-citationInfluenza virus-related critical illness: pathophysiology and epidemiology
Kalil, A. C., & Thomas, P. G. (2019) · Critical Care · doi:10.1186/s13054-019-2539-x · Cited by 524
Aliberti, S., Dela Cruz, C. S., Amati, F., Sotgiu, G., & Restrepo, M. I. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00630-9 · Cited by 305
Community-acquired Pneumonia and Hospital-acquired Pneumonia
Lanks, C. W., Musani, A. I., & Hsia, D. W. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.008 · Cited by 297
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., Nobre, V., Ramirez, P., Rouze, A., Salluh, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-022-06956-y · Cited by 292
Self-citation
Metadata
- Authors
- Self, W. H., Balk, R. A., Grijalva, C. G., Williams, D. J., Zhu, Y., Anderson, E. J., Waterer, G. W., Courtney, D. M., Bramley, A. M., Trabue, C., Fakhran, S., Blaschke, A. J., Jain, S., Edwards, K. M., & Wunderink, R. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-12
- Volume
- 65
- Issue
- 2
- Pages
- 183-190
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4297067969
- Cited by
- 257
- References
- 29
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.